|
| (3Z)-5-bromo-3-{4-oxo-2-thioxo-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene}-1,3-dihydro-2H-indol-2-one |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| 5-cyano-6-[(4-methylphenyl)methylsulfanyl]pyridine-2-carboxylic acid |
|
Escherichia
Yersinia |
TTSS (Type III secretion system)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Pan NJ, et al. 2009. Antimicrob Agents Chemother
|
|
| 5-[3'-(4-methylphenyl)-1'-phenyl-5-(2-thienyl)-3,4-dihydro-1'H,2H-3,4'-bipyrazol-2-yl]-5-oxopentanoic acid |
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Pan NJ, et al. 2009. Antimicrob Agents Chemother |
|
| 5-[5-[(E)-3-[[(1S)-1-carboxy-2-(4-nitrophenyl)ethyl]amino]-3-oxoprop-1-enyl]furan-2-yl]-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Leone M, et al. 2010. Chem Biol Drug Des |
|
| 5-[5-[(E)-3-[[3-[[4-(3,4-difluorophenyl)-1,3-thiazol-2-yl]amino]-3-oxopropyl]amino]-3-oxoprop-1-enyl]furan-2-yl]-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Leone M, et al. 2010. Chem Biol Drug Des |
|
| (Z)-5-(5-((2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Tautz L, et al. 2005. J Biol Chem |
|
| 5-[5-(2,3-Dihydro-6,7-dimethyl-3-oxothiazolo[3,2-a]benzimidazole-2-ylidenemethyl)-2-furanyl]-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Tautz L, et al. 2005. J Biol Chem |
|
| 5-[5-[(Z)-[[6-(4-fluoroanilino)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]hydrazinylidene]methyl]furan-2-yl]-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| 5-({1-[(2-chloro-1,3-thiazol-5-yl)methyl]-1H-indol-3-yl}methylene)-1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| 5-({(E)-[2-(4-chlorophenyl)-5-oxo-1,3-oxazol-4(5H)-ylidene]methyl}amino)-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| | | |
